Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma

Journal of Gastroenterology

Volumn 46, Issue 6, 2011, Pages 809-821

  Jo, Masayasu ^a   Nishikawa, Taichiro ^a   Nakajima, Tomoki ^a   Okada, Yoshihisa ^a   Yamaguchi, Kanji ^a   Mitsuyoshi, Hironori ^a   Yasui, Kohichiroh ^a   Minami, Masahito ^a   Iwai, Masaki ^a   Kagawa, Keizo ^a   Itoh, Yoshito ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Akt; Angiogenesis; Hepatocellular carcinoma; Oxidative stress; Vascular endothelial growth factor

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE; ANGIOGENIC FACTOR; HYDROGEN PEROXIDE; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; WORTMANNIN;

ADULT; AGED; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FEMALE; FIBROBLAST; GROWTH STIMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MICROVASCULATURE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; TUMOR VOLUME; UMBILICAL VEIN ENDOTHELIAL CELL;

ACETYLCYSTEINE; ADULT; AGED; ANDROSTADIENES; ANTIOXIDANTS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960245264     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0392-z     Document Type: Article

References (41)

1. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States. Ann Intern Med. 2003;139:817-23.
2. Reid AE. Non-alcoholic steatohepatitis. Gastroenterology. 2001;121:710-23.
3. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002;36:1349-54. (Pubitemid 35403524)
4. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology. 2002;122:1609-19. (Pubitemid 34533556)
5. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg. 2002;235:466-86. (Pubitemid 34258345)
6. Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, et al. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol. 1998;29:986-91. (Pubitemid 28422048)
7. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology. 1998;27:1554-62. (Pubitemid 28264678)
8. Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005;10:1881-96. (Pubitemid 40529044)
9. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA. 1994;91:4130-4. (Pubitemid 24143386)
10. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans. 2003;31: 1441-4. (Pubitemid 38030996)
11. Maulik N, Das DK. Redox signaling vascular angiogenesis. Free Radic Biol Med. 2002;33:1047-60.
12. Nakajima T, Moriguchi M, Katagishi T, Sekoguchi S, Nishikawa T, Takashima H, et al. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. Liver Int. 2006;26:23-31.
13. Sekoguchi S, Nakajima T, Moriguchi M, Jo M, Nishikawa T, Katagishi T, et al. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2007;22:182-90. (Pubitemid 46181347)
14. Nishikawa T, Nakajima T, Katagishi T, Okada Y, Jo M, Kagawa K, et al. Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation. Liver Int. 2009;29:846-56.
15. Szatrowski TP, Nathan CF. Production of large amount of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51: 794-8.
16. Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, et al. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology. 1996;23:455-64. (Pubitemid 26087158)
17. Skinner HD, Zheng JZ, Fang J, Agani F, Jiang BH. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J Biol Chem. 2004;279:45643-51. (Pubitemid 39491552)
18. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA. 1998;95:11715-20. (Pubitemid 28460480)
19. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-20. (Pubitemid 24166476)
20. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis, metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
21. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-20- deoxyguanosine as a biomarker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA. 1989;86:9697-701. (Pubitemid 20030700)
22. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-20- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res. 1997;387:147-63. (Pubitemid 28009270)
23. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, et al. Normalization of elevated hepatic 8-hydroxy-20-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res. 2001;61:8697-702. (Pubitemid 34013879)
24. Maeda K, Koda M, Matono T, Sugihara T, Yamamoto S, Ueki M, et al. Preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation in rats. Hepatol Res. 2008;38:727-35. (Pubitemid 351784986)
25. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918-26. (Pubitemid 351206771)
26. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, et al. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol. 2006;44: 1074-82.
27. Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, et al. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1a expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med. 2006;41:1521-33. (Pubitemid 44528250)
28. Jüngst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, et al. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology. 2004;39: 1663-72. (Pubitemid 38702668)
29. Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, et al. Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol. 2008;26:2992-8.
30. Zhou Q, Liu LZ, Fu B, Hu X, Shi X, Fang J, et al. Reactive oxygen species regulate insulin-induced VEGF and HIF-1a expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis. 2007;28:28-37. (Pubitemid 44942624)
31. Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007;67: 10823-30. (Pubitemid 350145911)
32. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000;60:1541-5. (Pubitemid 30183422)
33. Tang J, Wang J, Kong X, Yang J, Guo L, Zheng F, et al. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp Cell Res. 2009;315:3521-31.
34. Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008;68:1777-85. (Pubitemid 351416563)
35. Lee JK, Edderkaoui M, Truong P, Ohno I, Jang KT, Berti A, et al. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases. Gastroenterology. 2007;133:1637-48. (Pubitemid 350029743)
36. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem. 2004;279:34643-54. (Pubitemid 39318094)
37. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science. 2006;313: 1785-7. (Pubitemid 44454154)
38. Gupta S, Kobayashi S, Phongkitkarun S, Broemeling LD, Kan Z. Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model. Invest Radiol. 2006;41:516-21. (Pubitemid 44284186)
39. Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol. 2008;103:914-21. (Pubitemid 351506379)
40. Wang B, Xu H, Gao ZQ, Ning HF, Sun YQ, Cao GW. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization. Acta Radiol. 2008;49:523-9.
41. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006;25:695-705.